Wall Street Teacher (a pseudonym) worked on Wall Street for several years in the fixed income area and now teaches and writes on financial topics (primarily regulation and markets). Current interests include the psychology of financial markets, the origins of chemistry/physics, synthetic... More
Significant volume pick-up today with strong upside pressure. Options contracts on the call side are also picking up some interest. Some of the price action could be based on short covering since the JPM deal did not seem to aid the bear's cause much based on its relatively small size and ease of absorption. Also, recent Form 4 filing confirmed that RJ Kirk was large buyer of the secondary . I suspect that FIDO was there in size as well.
Three things to watch here:
1) If bull push continues we may see a bit of a squeeze as the short still stands at approx. 8 million shares.
2) Will JPM (lead on the recent offering) pick up coverage once the "quiet period" is lifted? If so, ZIOP would get exposed to an entirely different universe of investors.
3) Will ZIOP use ASCO to showcase progress with Intexon platform and/or Dr. Norton's oral programs?
Not many milestones scheduled over the short term. I expect PICASSO III results (STS-Palifosfamide) to be released late Fall and the company has expressed its intent to begin work on SCLC (Palifosfamide) profram late this year.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha
community. Instablog posts are not selected, edited or screened by Seeking Alpha editors,
in contrast to contributors' articles.
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.
ZIOP- Has The Tide Finally Turned? 0 comments
Three things to watch here:
1) If bull push continues we may see a bit of a squeeze as the short still stands at approx. 8 million shares.
2) Will JPM (lead on the recent offering) pick up coverage once the "quiet period" is lifted? If so, ZIOP would get exposed to an entirely different universe of investors.
3) Will ZIOP use ASCO to showcase progress with Intexon platform and/or Dr. Norton's oral programs?
Not many milestones scheduled over the short term. I expect PICASSO III results (STS-Palifosfamide) to be released late Fall and the company has expressed its intent to begin work on SCLC (Palifosfamide) profram late this year.
Disclosure: I am long ZIOP, TC, LGND, CRMD.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
Share this Instablog
Latest Followers
StockTalks
-
I'm betting Europe works out. That's bad for the $ but good for gold. I guess the Germans rule the continent without having to fire a shot!
Jun 4, 2012
-
ZIOP remains under pressure with the rest of the biotech space. Nice hire a few weeks back.
Jul 30, 2011
-
Well, I guess we will soon see if the speculation concerning a CLDA funds move to ZIOP is correct. Deal is scheduled to close early April.
Mar 31, 2011
More »Latest Comments
Most Commented
Posts by Themes